These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11303821)

  • 1. Macrocytosis in patients on stavudine.
    Eyer-Silva WA; Arabe J; Pinto JF; Morais-De-Sá CA
    Scand J Infect Dis; 2001; 33(3):239-40. PubMed ID: 11303821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stavudine-induced macrocytosis during therapy for human immunodeficiency virus infection.
    Martin GJ; Blazes DL; Mayers DL; Spooner KM
    Clin Infect Dis; 1999 Aug; 29(2):459-60. PubMed ID: 10476771
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrocytosis as an indicator of medication (zidovudine) adherence in patients with HIV infection.
    Romanelli F; Empey K; Pomeroy C
    AIDS Patient Care STDS; 2002 Sep; 16(9):405-11. PubMed ID: 12396692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes of macrocytosis in HIV-infected patients not treated with zidovudine. Swiss HIV Cohort Study.
    Geené D; Sudre P; Anwar D; Goehring C; Saaïdia A; Hirschel B
    J Infect; 2000 Mar; 40(2):160-3. PubMed ID: 10841093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stavudine induced macrocytosis.
    Ahmad S; Sukthankar A
    Genitourin Med; 1997 Oct; 73(5):421. PubMed ID: 9534760
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrocytosis is a predictor of resting lactate concentrations in persons on dideoxynucleoside therapy for HIV infection.
    Wobeser W; Morgan E; Rumman A; Ford PM
    Int J Infect Dis; 2012 Apr; 16(4):e225-7. PubMed ID: 22325033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamivudine-associated macrocytosis in HIV-infected patients.
    Khawcharoenporn T; Shikuma CM; Williams AE; Chow DC
    Int J STD AIDS; 2007 Jan; 18(1):39-40. PubMed ID: 17326861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mean corpuscular volume (MCV) values reflect therapeutic effectiveness in zidovudine-receiving HIV patients.
    Kim AH; Jang W; Kim Y; Park YJ; Han K; Oh EJ
    J Clin Lab Anal; 2013 Sep; 27(5):373-8. PubMed ID: 24038222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of antiretroviral therapy on occurrences of macrocytosis in patients with HIV/AIDS in Maringá, State of Paraná].
    Oliveira OC; Oliveira RA; Souza Ldo R
    Rev Soc Bras Med Trop; 2011; 44(1):35-9. PubMed ID: 21340405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of treatment-limiting anemia after substitution of zidovudine for stavudine in HIV-infected adult patients on antiretroviral treatment.
    Phe T; Thai S; Veng C; Sok S; Lynen L; van Griensven J
    PLoS One; 2013; 8(3):e60206. PubMed ID: 23555926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group.
    Spruance SL; Pavia AT; Mellors JW; Murphy R; Gathe J; Stool E; Jemsek JG; Dellamonica P; Cross A; Dunkle L
    Ann Intern Med; 1997 Mar; 126(5):355-63. PubMed ID: 9054279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
    Laurent C; Bourgeois A; Mpoudi-Ngolé E; Ciaffi L; Kouanfack C; Mougnutou R; Nkoué N; Calmy A; Koulla-Shiro S; Delaporte E
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):393-9. PubMed ID: 18327976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of Macrocytosis after Discontinuation of Zidovudine in HIV-Infected Patients.
    Yu I; Greenberg RN; Crawford TN; Thornton AC; Myint T
    J Int Assoc Provid AIDS Care; 2017; 16(5):512-515. PubMed ID: 28393661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stavudine: an update of its use in the treatment of HIV infection.
    Hurst M; Noble S
    Drugs; 1999 Nov; 58(5):919-49. PubMed ID: 10595868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stavudine-associated peripheral neuropathy in zidovudine-naïve patients: effect of stavudine exposure and antiretroviral experience.
    Scarsella A; Coodley G; Shalit P; Anderson R; Fisher RL; Liao Q; Ross LL; Hernandez JE
    Adv Ther; 2002; 19(1):1-8. PubMed ID: 12008857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).
    Eron JJ; Murphy RL; Peterson D; Pottage J; Parenti DM; Jemsek J; Swindells S; Sepulveda G; Bellos N; Rashbaum BC; Esinhart J; Schoellkopf N; Grosso R; Stevens M
    AIDS; 2000 Jul; 14(11):1601-10. PubMed ID: 10983647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidine analogue mutations in antiretroviral-naive HIV-1 patients on triple therapy including either zidovudine or stavudine.
    Bocket L; Yazdanpanah Y; Ajana F; Gerard Y; Viget N; Goffard A; Alcaraz I; Wattré P; Mouton Y
    J Antimicrob Chemother; 2004 Jan; 53(1):89-94. PubMed ID: 14645320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An antiretroviral regimen containing 6 months of stavudine followed by long-term zidovudine for first-line HIV therapy is optimal in resource-limited settings: a prospective, multicenter study in China.
    Li T; Guo F; Li Y; Zhang C; Han Y; Lye W; He Y; Lu H; Xie J; Huang A; Li Y; Tang X; Wang H; Zhang T; Gao G; Lei J; Zhang X; Wu X; Sun Y; Bai J; Luo L; Wang H
    Chin Med J (Engl); 2014; 127(1):59-65. PubMed ID: 24384425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of mean corpuscular volume (MCV) between thalassemia-carrier and non-thalassemia-carrier pregnant women receiving highly active antiretroviral therapy (HAART).
    Thongyou Y; Tongprasert F
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):736-739. PubMed ID: 29241911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stavudine versus zidovudine and the development of lipodystrophy.
    Bogner JR; Vielhauer V; Beckmann RA; Michl G; Wille L; Salzberger B; Goebel FD
    J Acquir Immune Defic Syndr; 2001 Jul; 27(3):237-44. PubMed ID: 11464142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.